首页> 外文OA文献 >Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

【2h】

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

机译：通过单克隆抗体D2C7对恶性胶质瘤的放射免疫靶向对野生型和变异III突变体表皮生长因子受体反应性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michael R. Zalutsky; Abraham Boskovitz; Chien-Tsun Kuan; Charles N. Pegram; Joanne Ayriss; Carol J. Wikstrand; Anne F. Buckley; Eric S. Lipp; James E. Herndon; Roger E. McLendon; Darell D. Bigner;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors [J] . ZalutskyM.R., BoskovitzA., KuanC.-T., Nuclear Medicine and Biology . 2012,第1期

机译：单克隆抗体D2C7对野生型和变体III突变型表皮生长因子受体有反应性，对恶性神经胶质瘤进行放射免疫靶向
2. Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFR [J] . Sharma Shringi, Mittapalli Rajendar K., Holen Kyle D., Clinical pharmacokinetics . 2015,第10期

机译：研究性抗表皮生长因子受体（EGFR）单克隆抗体ABT-806的种群药代动力学，可能是过度表达的野生型EGFR或表达变体III突变型EGFR的晚期实体瘤类型
3. Population Pharmacokinetics of ABT-806, an Investigational Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody, in Advanced Solid Tumor Types Likely to Either Over-Express Wild-Type EGFR or Express Variant III Mutant EGFR [J] . Sharma Shringi, Mittapalli Rajendar K., Holen Kyle D., Clinical pharmacokinetics . 2015,第10期

机译：ABT-806的人口药代动力学，一种研究抗表皮生长因子受体（EGFR）单克隆抗体，其在可能过度高表达野生型EGFR或Expressiant III突变体EGFR中
4. Antibody Production of Wild-Type and enzyme V279F Variants of PAF-AH as a Risk Factor for Cardiovascular Disease [C] . Anggia N. Ramadhani, Sapti Puspitarini, Anissa N. Sari, International Conference on Global Resource Conservation . 2017

机译：PAF-α的野生型和酶V279F变体的抗体生产作为心血管疾病的危险因素
5. Epidermal growth factor receptor (EGFR) mutations and tumor-specific targeting of malignant glioma by vaccine-based immunotherapeutic approaches. [D] . Ciesielski, Michael John. 2003

机译：表皮生长因子受体（EGFR）突变和恶性神经胶质瘤的肿瘤特异性靶向通过基于疫苗的免疫治疗方法。
6. Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors [O] . Michael R. Zalutsky, Abraham Boskovitz, Chien-Tsun Kuan, -1

机译：通过单克隆抗体D2C7对恶性胶质瘤的放射免疫靶向对野生型和变异III突变体表皮生长因子受体反应性
7. Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell Radiosensitivity [O] . Guido Lammering, Theodore H. Hewit, Mathew Holmes, 2004

机译：通过优势阴性EGFR-CD533抑制III型表皮生长因子受体变体变体突变体受体增强了恶性胶质瘤细胞辐射敏感性
8. Epidermal growth factor (EGF) as a potential targeting agent for delivery of boron to malignant gliomas [R] . Capala, J. , Barth, R. F. , Adams, D. M. , 1994

机译：表皮生长因子（EGF）作为将硼递送至恶性神经胶质瘤的潜在靶向剂

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

著录项

引文网络

相似文献

相关主题

期刊订阅